Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Inclusion Criteria: * Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms; * Men aged 18 years or over and less than or equal to 60 years with a diagnosis of Androgenetic Alopecia grades IIIv to IV in the modified Norwood-Hamilton classification, who have been using minoxidil 5% for at least 3 months and willing to maintain the same style, approximate length and hair color throughout the test. Exclusion Criteria: * Known hypersensitivity to the formula components used during the clinical trial; * History of alcohol and/or substance abuse within 2 years; * Participants with other concomitant dermatological diseases on the scalp, except for mild seborrhoea dermatitis; * Participants with a history of surgical treatment for hair loss or shaved scalp; * Participants who used shampoo or topical solution containing ketoconazole, tar, selenium, threonine or steroids in the last 2 weeks; * Participants who used 5α reductase inhibitors, such as finasteride and dutasteride, in the last 12 months; * Participants using testosterone replacement therapy (TRT) or using testosterone-containing gel; * Participants who used micro-infusion of medications on the skin (MMP), microneedling or intradermotherapy on the scalp in the last 3 months; * Participants who have undergone radiation treatment for the scalp or chemotherapy in the past year; * Participants with diseases that can affect hair growth; * Participants with a current medical history of cancer and / or cancer treatment in the last 5 years;